Literature DB >> 8095255

Interstitial cells from the atrial and ventricular sides of the bovine mitral valve respond differently to denuding endocardial injury.

W M Lester1, A A Damji, I Gedeon, M Tanaka.   

Abstract

The mitral valve has atrial and ventricular sides, each lined by endocardial cells. The valve stroma contains alpha smooth muscle actin positive interstitial cells, collagen, glycosaminoglycans, and elastic tissue. To eliminate the effect of endocardium on wound repair in bovine mitral valve organ culture, the endocardium was removed from both sides of the valve. At 6 days, organ cultures of these preparations revealed surface cells on the ventricular side but not in the atrial side. Ventricular surface cells were negative for Factor VIII-related antigen, and positive for alpha smooth muscle actin. Immunoperoxidase staining for proliferating cell nuclear antigen/cyclin, a marker for cell proliferation, revealed a positive labeling index of (mean +/- standard deviation) 0.08 +/- 0.16% for interstitial cells from the atrial side and 0.14 +/- 0.19% for ventricular side interstitial cells in uncultured preparations (not significant), and 0.44 +/- 0.69% for atrial side interstitial cells and 2.25 +/- 1.64% for ventricular side interstitial cells in the cultured preparations (significant, P < 0.0006). The results suggest that in organ culture, interstitial cells from the ventricular side of the mitral valve respond to a denuding endocardial injury by proliferating and migrating onto the adjacent surface whereas interstitial cells from the atrial side do not. This difference in the response to injury of interstitial cells from the atrial and ventricular sides of the valve may reflect differences in phenotype or may be due to effects of extracellular matrix on interstitial cell behavior. The latter is possible because of differences in the extracellular matrix of the atrial and ventricular sides of the valve.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8095255     DOI: 10.1007/bf02634370

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol        ISSN: 0883-8364


  40 in total

1.  Characterization of Cobblestone mitral valve interstitial cells.

Authors:  S Zacks; A Rosenthal; B Granton; M Havenith; M Opas; A I Gotlieb
Journal:  Arch Pathol Lab Med       Date:  1991-08       Impact factor: 5.534

Review 2.  Universal control mechanism regulating onset of M-phase.

Authors:  P Nurse
Journal:  Nature       Date:  1990-04-05       Impact factor: 49.962

3.  Myofibroblasts in human granulation tissue.

Authors:  G B Ryan; W J Cliff; G Gabbiani; C Irlé; D Montandon; P R Statkov; G Majno
Journal:  Hum Pathol       Date:  1974-01       Impact factor: 3.466

Review 4.  Endothelial cell influences on vascular smooth muscle phenotype.

Authors:  J H Campbell; G R Campbell
Journal:  Annu Rev Physiol       Date:  1986       Impact factor: 19.318

5.  Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis.

Authors:  R L Garcia; M D Coltrera; A M Gown
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

6.  Interstitial cells of the heart valves possess characteristics similar to smooth muscle cells.

Authors:  D A Filip; A Radu; M Simionescu
Journal:  Circ Res       Date:  1986-09       Impact factor: 17.367

7.  Type I and type IV collagen promote adherence and spreading of human type II pneumocytes in vitro.

Authors:  T Papadopoulos; L Ionescu; J Dämmrich; H Toomes; H K Müller-Hermelink
Journal:  Lab Invest       Date:  1990-05       Impact factor: 5.662

8.  Chemotactic responses of fibroblasts to tropoelastin and elastin-derived peptides.

Authors:  R M Senior; G L Griffin; R P Mecham
Journal:  J Clin Invest       Date:  1982-09       Impact factor: 14.808

9.  Cell specific effects of glycosaminoglycans on the attachment and proliferation of vascular wall components.

Authors:  A Orlidge; P A D'Amore
Journal:  Microvasc Res       Date:  1986-01       Impact factor: 3.514

10.  Monoclonal antibodies to a nuclear protein (PCNA/cyclin) associated with DNA replication.

Authors:  K Ogata; P Kurki; J E Celis; R M Nakamura; E M Tan
Journal:  Exp Cell Res       Date:  1987-02       Impact factor: 3.905

View more
  6 in total

Review 1.  The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology.

Authors:  Amber C Liu; Vineet R Joag; Avrum I Gotlieb
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

2.  Active adaptation of the tethered mitral valve: insights into a compensatory mechanism for functional mitral regurgitation.

Authors:  Jacob P Dal-Bianco; Elena Aikawa; Joyce Bischoff; J Luis Guerrero; Mark D Handschumacher; Suzanne Sullivan; Benjamin Johnson; James S Titus; Yoshiko Iwamoto; Jill Wylie-Sears; Robert A Levine; Alain Carpentier
Journal:  Circulation       Date:  2009-07-13       Impact factor: 29.690

3.  Design and validation of a novel splashing bioreactor system for use in mitral valve organ culture.

Authors:  Janet E Barzilla; Anna S McKenney; Ashley E Cowan; Christopher A Durst; K Jane Grande-Allen
Journal:  Ann Biomed Eng       Date:  2010-07-27       Impact factor: 3.934

4.  Extracellular matrix remodeling in wound healing of critical size defects in the mitral valve leaflet.

Authors:  Elizabeth H Stephens; Tom C Nguyen; Jack G Blazejewski; Dragoslava P Vekilov; Jennifer P Connell; Akinobu Itoh; Neil B Ingels; D Craig Miller; K Jane Grande-Allen
Journal:  Heart Vessels       Date:  2015-11-12       Impact factor: 2.037

5.  Hemodynamics and mechanobiology of aortic valve inflammation and calcification.

Authors:  Kartik Balachandran; Philippe Sucosky; Ajit P Yoganathan
Journal:  Int J Inflam       Date:  2011-07-06

6.  MG 53 Protein Protects Aortic Valve Interstitial Cells From Membrane Injury and Fibrocalcific Remodeling.

Authors:  T M Ayodele Adesanya; Melanie Russell; Ki Ho Park; Xinyu Zhou; Matthew A Sermersheim; Kristyn Gumpper; Sara N Koenig; Tao Tan; Bryan A Whitson; Paul M L Janssen; Joy Lincoln; Hua Zhu; Jianjie Ma
Journal:  J Am Heart Assoc       Date:  2019-02-19       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.